Related Experiment Video
Updated: May 24, 2025
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Update on Pediatric Hepatitis C Infection
Johanna Ferreira1, Shari Sheflin-Findling2
1Division of Pediatric Gastroenterology, Liver Disease and Nutrition, Cohen Children's Medical Center/Northwell, The Zucker School of Medicine at Hofstra, 1991 Marcus Avenue, Suite M100 , Lake Success, NY, 11042, USA. jferreira1@northwell.edu.
Insights
Hepatitis C virus (HCV) screening and direct-acting antiviral treatments offer high cure rates in children. Continued efforts are needed for HCV elimination through improved access and vaccine development.
Area of Science:
- Pediatric Infectious Diseases
- Hepatology
- Public Health
Background:
- Hepatitis C virus (HCV) infections are increasing in the U.S.
- HCV poses a significant public health challenge, particularly in pediatric populations.
Purpose of the Study:
- To provide a comprehensive overview of HCV infection in children.
- To focus on recent advancements in screening, diagnosis, and treatment of pediatric HCV.
Main Methods:
- Review of current screening strategies for pregnant women and infants.
- Analysis of direct-acting antiviral (DAA) therapies for pediatric patients.
- Examination of challenges and future directions in HCV elimination.
Main Results:
- Effective screening includes universal screening of pregnant women and nucleic acid testing for infants.
- Direct-acting antiviral agents demonstrate high cure rates in children across all age groups.
- Significant progress has been made, but challenges in access to testing and treatment persist.
Conclusions:
- HCV treatment in children has been revolutionized by DAAs, achieving high cure rates.
- Achieving HCV elimination requires improved access to diagnostics and therapeutics.
- Development of a preventive vaccine and continued research are crucial for reducing the burden of pediatric HCV.
Purposeof Review:
Hepatitis C virus (HCV) infections continue to steadily increase in the United States and remain a major public health challenge. This review aims to provide a comprehensive overview of HCV infection in children, focusing on recent advancements in screening, diagnosis, and treatment.
Recent Findings:
Effective screening strategies, including universal screening of pregnant women and nucleic acid testing for all perinatally exposed infants at 2 to 6 months of age, have been implemented to identify infected individuals early. Direct-acting antiviral agents have revolutionized treatment, offering high cure rates for children of all ages. Despite significant progress, challenges remain in achieving HCV elimination. These include the need for improved access to testing and treatment, as well as ongoing efforts to develop a preventive vaccine. Continued research and implementation of effective strategies are essential to reduce the burden of HCV infection.
